In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

How to ensure protection of patients at risk for SCD? An approach to screening

EHRA webinar

Add to calendar11/03/20150:00 11/03/20150:00 Europe/Paris How to ensure protection of patients at risk for SCD? An approach to screening European Heart Rhythm Association DD/MM/YYYY
Sudden Cardiac Death and Resuscitation
Risk Factors, Epidemiology, Rehabilitation and Sports Cardiology

This webinar reviews current risk stratification tools for different cardiac conditions (cardiomyopathies, channelopathies) that are associated with an increased risk of SCD. The clinical value of using the life vest for SCD protection will be discussed.

John Morgan and Stefan Winter.

The EHRA Webinars are designed to help you improve your daily practice.

The format includes a case based presentation, online assessment and live discussions with the two key opinion leaders who will give you some useful tips for your daily clinical practice.


Watch the webinar recording


  • Salomon: Sudden Death in Myocardial Infarction and Left ventricular Dysfunction, Heart failure or both. N Engl J Med 2008; 358:1615-1616
  • Steinbeck : Defibrillator Implantation early after Myocardial Infarction. N Engl J Med 2009;361:1427-1436
  • Hohnloser: Prophylactic use of an implantable Cardioverter Defibrillator  after Acute Myocardial Infarction, N Engl J Med; Volume 351;24:2481-2488; December 9, 2004
  • ESC-Guidelines for acute and chronic heart failure 2012

This programme is supported by Zoll in the form of unrestricted educational grants.

The scientific programme has not been influenced in any way by its sponsor.